Insiders · IMGO

Amy E. Tapper

Officer at Imago BioSciences, Inc. (IMGO)

Amy E. Tapper has filed 12 insider reports with the SEC since November 2021, as officer at Imago BioSciences, Inc. (IMGO). Amy E. Tapper made no open-market purchases or sales in the last 12 months. The latest filing, on January 11, 2023, reports sale back to the company and tender of shares in a change of control at Imago BioSciences, Inc. (IMGO).

Filings
12
Companies
1
Bought on market
None
Sold on market
$4.23M

Companies where Amy E. Tapper is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Imago BioSciences, Inc. logo
IMGO
Imago BioSciences, Inc.
Officer0$4.23MJan 11, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Amy E. Tapper with

Questions about Amy E. Tapper

What is Amy E. Tapper's role at Imago BioSciences, Inc.?
Amy E. Tapper reports to the SEC as officer at Imago BioSciences, Inc. (IMGO), according to the latest filing on January 11, 2023.
Has Amy E. Tapper bought or sold stock recently?
The most recent open-market sale was on December 16, 2022: sold 100,302 shares of Imago BioSciences, Inc. (IMGO) for $3.59M at an average of $35.78.
How do I get alerts when Amy E. Tapper files?
Follow Amy E. Tapper on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Amy E. Tapper (SEC CIK 0001861069). Totals count each trade once, skipping amendments whose original is on file, from Nov 19, 2021 on. View on SEC EDGAR · Get this as JSON